Erythema Multiforme: Recognition and Management.
Trayes KP, Love G, Studdiford JS.
Am Fam Physician. 2019 Jul 15;100(2):82-88.
Herpes simplex virus gene therapy for dystrophic epidermolysis bullosa (DEB).
Epstein AL, Haag-Molkenteller C.
Cell. 2023 Aug 17;186(17):3523-3523.e1. doi: 10.1016/j.cell.2023.07.031.
Beremagene Geperpavec: First Approval.
Dhillon S.
Drugs. 2023 Aug;83(12):1131-1135. doi: 10.1007/s40265-023-01921-5.
Recent Updates in the Treatment of Erythema Multiforme.
Soares A, Sokumbi O.
Medicina (Kaunas). 2021 Sep 1;57(9):921. doi: 10.3390/medicina57090921.
Ramsay Hunt Syndrome: An Introduction, Signs and Symptoms, and Treatment.
Goswami Y, Gaurkar SS.
Cureus. 2023 Jan 12;15(1):e33688. doi: 10.7759/cureus.33688. eCollection 2023 Jan.
Toxic epidermal necrolysis and Stevens-Johnson syndrome.
Harr T, French LE.
Orphanet J Rare Dis. 2010 Dec 16;5:39. doi: 10.1186/1750-1172-5-39.
Pemphigus vulgaris and herpes simplex virus: Imperfect together.
Heymann WR.
J Am Acad Dermatol. 2023 Mar;88(3):549-550. doi: 10.1016/j.jaad.2023.01.018. Epub 2023 Jan 28.
Trial of Beremagene Geperpavec (B-VEC) for Dystrophic Epidermolysis Bullosa.
Guide SV, Gonzalez ME, Bağcı IS, Agostini B, Chen H, Feeney G, Steimer M, Kapadia B, Sridhar K, Quesada Sanchez L, Gonzalez F, Van Ligten M, Parry TJ, Chitra S, Kammerman LA, Krishnan S, Marinkovich MP.
N Engl J Med. 2022 Dec 15;387(24):2211-2219. doi: 10.1056/NEJMoa2206663.
Erythema multiforme: a review of epidemiology, pathogenesis, clinical features, and treatment.
Samim F, Auluck A, Zed C, Williams PM.
Dent Clin North Am. 2013 Oct;57(4):583-96. doi: 10.1016/j.cden.2013.07.001.
Erythema multiforme, Stevens-Johnson syndrome/toxic epidermal necrolysis - diagnosis and treatment.
Grünwald P, Mockenhaupt M, Panzer R, Emmert S.
J Dtsch Dermatol Ges. 2020 Jun;18(6):547-553. doi: 10.1111/ddg.14118. Epub 2020 May 29.
